First implicated in the development of malignant mesothelioma and uveal melanoma, germline BRCA1-associated protein-1 (BAP1) mutations are a relatively recently discovered tumor predisposition syndrome [40]. This evidence concerns the gene BAP1 and BAP1-related tumor predisposition syndrome.